Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Cash from Financing Activities (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Cash from Financing Activities data on record, last reported at -$1000.0 in Q4 2019.

  • For Q4 2019, Cash from Financing Activities fell 100.01% year-over-year to -$1000.0; the TTM value through Dec 2019 reached $70000.0, down 99.67%, while the annual FY2024 figure was $12.0 million, 67.44% down from the prior year.
  • Cash from Financing Activities reached -$1000.0 in Q4 2019 per DMAC's latest filing, roughly flat from -$1000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $14.8 million in Q4 2018 and bottomed at -$2000.0 in Q1 2019.